首页> 外国专利> METHOD OF SCREENING SAMPLE HAVING ANTIVIRAL ACTIVITY AGAINST VIRUS WITH ABILITY TO INFECT ORGANISM EXHIBITING ACQUIRED IMMUNE MECHANISM BY USE OF INDIVIDUAL ORGANISM, OR ITS CULTURED CELL, EXHIBITING NATURAL IMMUNE MECHANISM ONLY, AND METHOD OF ESTIMATING THE ANTIVIRAL ACTIVITY BY USE OF INDIVIDUAL ORGANISM, OR ITS CULTURED

METHOD OF SCREENING SAMPLE HAVING ANTIVIRAL ACTIVITY AGAINST VIRUS WITH ABILITY TO INFECT ORGANISM EXHIBITING ACQUIRED IMMUNE MECHANISM BY USE OF INDIVIDUAL ORGANISM, OR ITS CULTURED CELL, EXHIBITING NATURAL IMMUNE MECHANISM ONLY, AND METHOD OF ESTIMATING THE ANTIVIRAL ACTIVITY BY USE OF INDIVIDUAL ORGANISM, OR ITS CULTURED

机译:筛选具有抗病毒能力的样本的方法,该病毒可通过使用单个生物体或培养的细胞感染具有所获得的免疫机制的有机体,包括自然免疫机制,或者仅通过一种生物来评估其自身的生物活性培养的

摘要

Results have proved that infection deaths by nuclear polyhedrosis viruses of silkworm larvae can be remedied by ganciclovir, foscarnet, vidarabine and ribavirin used as therapeutic drugs for cytomegalus virus infection at human clinic. Findings indicate that the use of individual organism, or its cultured cell, exhibiting natural immune mechanism only, such as silkworm larva, leads to realization of screening of a sample having an antiviral activity against virus with ability to infect an organism exhibiting acquired immune mechanism, such as human, and realization of estimation of the antiviral activity.
机译:结果证明,在人类临床中,更昔洛韦,膦甲膦酸钠,维达拉滨和利巴韦林可以作为治疗巨细胞病毒感染的治疗药物,来弥补家蚕幼虫多角体病毒引起的感染死亡。研究结果表明,仅使用具有天然免疫机制的单个生物体或其培养细胞(例如蚕幼虫),就可以筛选出具有抗病毒活性且能够感染具有获得性免疫机制的生物体的病毒的样品,例如人类,并实现抗病毒活性的估计。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号